The DOI matches its Crossref record; 403 of the 403 references it cites were found in a registry or an index.
Frontiers in the treatment of glioblastoma: Past, present and emerging
Abstract
Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive research over the last several decades, the survival rates for GBM have not improved and prognosis remains poor. To date, only a few therapies are approved for the treatment of GBM with the main reasons being: 1) significant tumour heterogeneity which promotes the selection of resistant subpopulations 2) GBM induced immunosuppression and 3) fortified location of the tumour in the brain which hinders the delivery of therapeutics. Existing therapies for GBM such as radiotherapy, surgery and chemotherapy have been unable to reach the clinical efficacy necessary to prolong patient survival more than a few months. This comprehensive review evaluates the current and emerging therapies including those in clinical trials that may potentially improve both targeted delivery of therapeutics directly to the tumour site and the development of agents that may specifically target GBM. Particular focus has also been given to emerging delivery technologies such as focused ultrasound, cellular delivery systems nanomedicines and immunotherapy. Finally, we discuss the importance of developing novel materials for improved delivery efficacy of nanoparticles and therapeutics to reduce the suffering of GBM patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 403
Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
Zottel, A., Paska, A. V., & Jovčevska, I. (2019) · Materials · doi:10.3390/ma12101588 · Cited by 158
Native albumin for targeted drug delivery
Neumann, E., Frei, E., Funk, D., Becker, M. D., Schrenk, H., Müller‐Ladner, U., & Fiehn, C. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.498474 · Cited by 156
Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse
Choi, M.-R., Bardhan, R., Stanton-Maxey, K. J., Badve, S., Nakshatri, H., Stantz, K. M., Cao, N., Halas, N. J., & Clare, S. E. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-012-0029-9 · Cited by 154
Anton, K., Baehring, J. M., & Mayer, T. M. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.04.006 · Cited by 153
Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers
Guérin, C. J., Olivi, A., WEINGART, J. D., Lawson, H. C., & Brem, H. (2003) · Investigational New Drugs · doi:10.1023/b:drug.0000006172.65135.3e · Cited by 153
Passero, F. C., Grapsa, D., Syrigos, K., & Saif, M. W. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1192471 · Cited by 152
Bertucci, A., Prasetyanto, E. A., Septiadi, D., Manicardi, A., Brognara, E., Gambari, R., Corradini, R., & Cola, L. D. (2015) · Small · doi:10.1002/smll.201500540 · Cited by 150
Virus-Based Immunotherapy of Glioblastoma
Martikainen, M., & Essand, M. (2019) · Cancers · doi:10.3390/cancers11020186 · Cited by 150
Mathupala, S. P., Parajuli, P., & Sloan, A. E. (2004) · Neurosurgery · doi:10.1227/01.neu.0000143034.62913.59 · Cited by 147
Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol
Summerlin, N., Qu, Z., Pujara, N., Sheng, Y., Jambhrunkar, S., McGuckin, M. A., & Popat, A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.076 · Cited by 147
Self-citationChaudhary, Z., Subramaniam, S., Khan, G. M., Abeer, M. M., Qu, Z., Janjua, T. I., Kumeria, T., Batra, J., & Popat, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00225 · Cited by 144
Self-citationUnderstanding Glioblastoma Tumor Biology: The Potential to Improve Current Diagnosis and Treatments
Kesari, S. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.09.005 · Cited by 143
Meyer, M. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc086380 · Cited by 143
Luo, M., Lewik, G., Ratcliffe, J., Choi, C. H. J., Mäkilä, E. M., Tong, W. Y., & Voelcker, N. H. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10787 · Cited by 137
VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
Goel, S., Chen, F., Hong, H., Valdovinos, H. F., Hernandez, R. T., Shi, S., Barnhart, T. E., & Cai, W. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am506849p · Cited by 136
Pang, L., Zhu, Y., Qin, J., Zhao, W., & Wang, J. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1502839 · Cited by 136
Mudassar, F., Shen, H. M., O’Neill, G. M., & Hau, E. K. C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01724-6 · Cited by 135
Oncolytic Virotherapy for the Treatment of Malignant Glioma
Foreman, P. M., Friedman, G. K., Cassady, K. A., & Markert, J. M. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0516-0 · Cited by 134
Bruinsmann, F. A., Vaz, G. R., Alves, A. D. C. S., Aguirre, T. A. S., Pohlmann, A. R., Guterres, S. S., & Sonvico, F. (2019) · Molecules · doi:10.3390/molecules24234312 · Cited by 134
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Weiss, T., Puca, E., Silginer, M., Hemmerle, T., Pazahr, S., Bink, A., Weller, M., Neri, D., & Roth, P. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb2311 · Cited by 133
iRGD Modified Chemo‐immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma
Kuang, J., Song, W. L., Yin, J., Zeng, X., Han, S. H., Zhao, Y., Tao, J., Liu, C., He, X., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800025 · Cited by 133
Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
Caffery, B., Lee, J. S., & Alexander-Bryant, A. A. (2019) · Nanomaterials · doi:10.3390/nano9010105 · Cited by 133
Reardon, D. A., Groves, M. D., Wen, P. Y., Nabors, B., Mikkelsen, T., Rosenfeld, S., Raizer, J. J., Barriuso, J., McLendon, R. E., Suttle, A. B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1707 · Cited by 132
Subchronic toxicity of silica nanoparticles as a function of size and porosity
Mohammadpour, R., Yazdimamaghani, M., Cheney, D. L., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.041 · Cited by 132
Zhao, M., Bozzato, E., Joudiou, N., Ghiassinejad, S., Danhier, F., Gallez, B., & Véronique Préat, A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.015 · Cited by 132
Oncolytic biotherapy: a novel therapeutic platform
Hawkins, L. K., Lemoine, N. R., & Kirn, D. H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00618-0 · Cited by 131
The solid progress of nanomedicine
Martins, J. P., das Neves, J., de la Fuente, M., Celia, C., Florindo, H. F., Günday-Türeli, N., Popat, A., Santos, J. L., Sousa, F., Schmid, R., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00743-2 · Cited by 131
Self-citationSilica nanoparticles: A promising platform for enhanced oral delivery of macromolecules
Abeer, M. M., Rewatkar, P. V., Qu, Z., Talekar, M., Kleitz, F., Schmid, R., Lindén, M., Kumeria, T., & Popat, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.021 · Cited by 131
Self-citationBagó, J. R., Alfonso-Pecchio, A. R., Okolie, O., Dumitru, R., Rinkenbaugh, A. L., Baldwin, A. S., Miller, C. R., Magness, S. T., & Hingtgen, S. (2016) · Nature Communications · doi:10.1038/ncomms10593 · Cited by 129
The Blood-Brain/Tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery
Zhan, C., & Lu, W. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112803341798 · Cited by 128
Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells
Zhang, B., Lung, P., Zhao, S., Chu, Z., Chrzanowski, W., & Li, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-07588-9 · Cited by 128
Liu, X., Jiang, J., Chan, R., Ji, Y. C., Lu, J., Liao, Y., Okene, M. O., Lin, J., Lin, P. K., Chang, C. H., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06164 · Cited by 128
Li, T., Li, K., Zhang, Q., Wang, C., Yue, Y., Chen, Z., Yuan, S.-J., Liu, X., Wen, Y., Han, M. H., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.035 · Cited by 127
Maksimenko, O., Malinovskaya, J. A., Шипуло, Е. В., Osipova, N., Razzhivina, V., Arantseva, D., Yarovaya, O. V., Леонидовна, М. У., Khalansky, A. S., Федосеева, В. В., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118733 · Cited by 127
Super‐Soft Hydrogel Particles with Tunable Elasticity in a Microfluidic Blood Capillary Model
Cui, J., Björnmalm, M., Liang, K., Xu, C., Best, J. P., Zhang, X., & Caruso, F. (2014) · Advanced Materials · doi:10.1002/adma.201402753 · Cited by 125
Beier, C. P., Schmid, C., Gorlia, T., Kleinletzenberger, C., Beier, D., Grauer, O., Steinbrecher, A., Hirschmann, B., Brawanski, A., Dietmaier, C., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-308 · Cited by 125
Mohammadpour, R., Cheney, D. L., Grunberger, J. W., Yazdimamaghani, M., Jedrzkiewicz, J., Isaacson, K. J., Dobrovolskaia, M. A., & Ghandehari, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.027 · Cited by 125
Kroll, R. A., Pagel, M. A., Muldoon, L. L., Roman-Goldstein, S., Neuwelt, E. A., Neuwelt, E. A., & Neuwelt, E. A. (1996) · Neurosurgery · doi:10.1097/00006123-199604000-00024 · Cited by 124
Fang, J., Lai, Y., Chiu, T., Chen, Y., Hu, S., & Chen, S. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300598 · Cited by 123
Saito, R., Bringas, J. R., Panner, A., Tamas, M., Pieper, R. O., Berger, M. S., & Bankiewicz, K. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1683 · Cited by 123
Florian, B.-A., Lamure, M. P., Ducray, F., Aulagner, G., Honnorat, J., & Armoiry, X. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now102 · Cited by 120
Meneï, P., Boisdron‐Celle, M., Croué, A., et al. (1996) · Neurosurgery · doi:10.1097/00006123-199607000-00023 · Cited by 119
Dante, S., Petrelli, A., Petrini, E. M., Marotta, R., Maccione, A., Alabastri, A., Quarta, A., Donato, F. D., Ravasenga, T., Sathya, A., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b00397 · Cited by 119
Kim, S. S., Rait, A. S., Kim, E. H., DEMARCO, J. P., Pirollo, K. F., & Chang, E. H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.022 · Cited by 118
Whittle, J. R., Lickliter, J. D., Gan, H. K., Scott, A. M., Simes, J. R., Solomon, B., MacDiarmid, J. A., Brahmbhatt, H. N., & Rosenthal, M. A. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.06.005 · Cited by 117
Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.
Pollack, I. F., Randall, M. S., Kristofik, M. P., Kelly, R. H., Selker, R. G., & Vertosick, F. T. (1990) · PubMed · Cited by 117
Bukara, K. M., Schueller, L., Rosier, J. A., Martens, M. A., Daems, T., Verheyden, L., Eelen, S., Speybroeck, M. V., Libanati, C., Martens, J. A., et al. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.020 · Cited by 117
Full-Process Radiosensitization Based on Nanoscale Metal–Organic Frameworks
Gong, T., Li, Y., Lv, B., Wang, H., Liu, Y., Yang, W., Wu, Y., Jiang, X., Gao, H., Zheng, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b07898 · Cited by 117
Targeting of nanoparticles in cancer
Talekar, M., Kendall, J. D., Denny, W. A., & Garg, S. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834a4554 · Cited by 115
Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression
Escobar, G., Moi, D., Ranghetti, A., Baydin, P. O., Squadrito, M. L., Kajaste‐Rudnitski, A., Bondanza, A., Gentner, B., Palma, M. D., Mazzieri, R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006353 · Cited by 114
Self-citationEffect of Surface Functionality of Silica Nanoparticles on Cellular Uptake and Cytotoxicity
Jambhrunkar, S., Qu, Z., Popat, A., Yang, J., Noonan, O., Acauan, L. H., Nor, Y. A., Yu, C., & Karmakar, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500385n · Cited by 113
Self-citationTemozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
Munoz, J. L., Walker, N. D., Scotto, K. W., & Rameshwar, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.013 · Cited by 110
Kozielski, K., Ruiz‐Valls, A., Tzeng, S. Y., Guerrero‐Cazares, H., Rui, Y., Li, Y., Vaughan, H. J., Gionet‐Gonzales, M., Vantucci, C. E., Kim, J., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.020 · Cited by 110
Gao, J.-H., Wang, Z., Liu, H., Wang, L., & Huang, G. (2015) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2015.01016 · Cited by 109
Lessons learned in the evolution of endoscopic skull base surgery
Schwartz, T. H., Morgenstern, P. F., & Anand, V. K. (2019) · Journal of neurosurgery · doi:10.3171/2018.10.jns182154 · Cited by 109
Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme
Nam, L. V., Coll, C., Erthal, L. C. S., de la Torre, C., Serrano, D. R., Martínez‐Máñez, R., Santos-Martínez, M. J., & Ruiz‐Hernández, E. (2018) · Materials · doi:10.3390/ma11050779 · Cited by 107
Lymphatic outflow of cerebrospinal fluid is reduced in glioma
Ma, Q., Schlegel, F., Bachmann, S. B., Schneider, H., Decker, Y., Rudin, M., Weller, M., Proulx, S. T., & Detmar, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51373-9 · Cited by 107
de Oliveira, E. R., Nascimento, T. L., Salomão, M. A., da Silva, A. C. G., Valadares, M. C., & Lima, E. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2662-z · Cited by 104
Polymer Delivery of Camptothecin against 9L Gliosarcoma: Release, Distribution, and Efficacy
Storm, P. B., Moriarity, J. L., Tyler, B., Burger, P. C., Brem, H., & WEINGART, J. D. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015003232713 · Cited by 103
Kumeria, T., McInnes, S. J. P., Maher, S., & Santos, A. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1317245 · Cited by 103
Self-citation(1974) · Journal of neurosurgery · doi:10.3171/jns.1974.41.3.0405 · Cited by 101
Anselmo, A. C., Kumar, S., Gupta, V., Pearce, A. M., Ragusa, A., Muzykantov, V. R., & Mitragotri, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.043 · Cited by 100
Use of nanoparticles for drug delivery in glioblastoma multiforme
Jain, K. K. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.4.363 · Cited by 99
An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.
Park, S. J., Smith, C. P., Wilbur, R. R., Cain, C. P., Kallu, S. R., Valasapalli, S., Sahoo, A., Guda, M. R., Tsung, A. J., & Velpula, K. K. (2018) · Europe PMC (PubMed Central) · Cited by 99
Juthani, R. G., Madajewski, B., Yoo, B., Zhang, L., Chen, P.-M., Chen, F., Turker, M. Z., Ma, K., Overholtzer, M., Longo, V. A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1834 · Cited by 98
Hubensack, M., Müller, C., Höcherl, P., Fellner, S., Spruß, T., Bernhardt, G., & Buschauer, A. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0323-9 · Cited by 97
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
Wang, S., Meng, Y., Li, C., Qian, M., & Huang, R. (2015) · Nanomaterials · doi:10.3390/nano6010003 · Cited by 97
Chen, K., Lin, Y.-J., Chai, W., Lin, C.-J., Chen, P., Huang, C.-Y., Kuo, J. S., Liu, H.-L., & Wei, K. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-344 · Cited by 97
Enderlin, M., Kleinmann, E. V., Struyf, S., Buracchi, C., Vecchi, A., Kinscherf, R., Kiessling, F. M., Paschek, S., Sozzani, S., Rommelaere, J., et al. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.62 · Cited by 95
Sabel, M., & Giese, A. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802508180 · Cited by 95
Strategies in Gene Therapy for Glioblastoma
Kwiatkowska, A., Nandhu, M. S., Behera, P., Chiocca, E. A., & Viapiano, M. S. (2013) · Cancers · doi:10.3390/cancers5041271 · Cited by 95
Sparreboom, A., Planting, A. S. T., Jewell, R. C., van der Burg, M. E., van der Gaast, A., de Bruijn, P., Loos, W. J., Nooter, K., Chandler, L. H., Paul, E. M., et al. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00005 · Cited by 94
Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier
Banks, W. A., Kastin, A. J., Fasold, M. B., Barrera, C. M., & Augereau, G. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90021-4 · Cited by 93
Gupta, R., Badhe, Y. P., Mitragotri, S., & Rai, B. (2020) · Nanoscale · doi:10.1039/c9nr09947f · Cited by 93
Molecularly targeted therapies for recurrent glioblastoma: current and future targets
Lau, D., Magill, S. T., & Aghi, M. K. (2014) · Neurosurgical FOCUS · doi:10.3171/2014.9.focus14519 · Cited by 92
Implantable drug delivery systems
Kumar, A., & Pillai, J. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813665-2.00013-2 · Cited by 92
Boumendjel, A., Leer, A. M., Champelovier, P., Allegro, D., Muhammad, D., Souard, F., Derouazi, M., Peyrot, V., Toussaint, B., & Boutonnât, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-242 · Cited by 89
Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma
Brachi, G., Ruiz-Ramírez, J., Dogra, P., Wang, Z., Vittorio Cristini, C., Ciardelli, G., Rostomily, R., Mauro Ferrari, B., Mikheev, A. M., Blanco, E., et al. (2020) · Nanoscale · doi:10.1039/d0nr05053a · Cited by 89
Current Vaccine Trials in Glioblastoma: A Review
Xu, L. W., Chow, K. K. H., Lim, M. K., & Li, G. (2014) · Journal of Immunology Research · doi:10.1155/2014/796856 · Cited by 87
PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review
Caccese, M., Indraccolo, S., Zagonel, V., & Lombardi, G. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.12.002 · Cited by 87
Tong, W. Y., Alnakhli, M., Bhardwaj, R., Apostolou, S., Sinha, S., Fraser, C. K., Kuchel, T. R., Kuss, B. J., & Voelcker, N. H. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0365-y · Cited by 86
Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors
Saucier-Sawyer, J. K., Seo, Y.-E., Gaudin, A., Quijano, E., Song, E., Sawyer, A. J., Deng, Y., Huttner, A. J., & Saltzman, W. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.006 · Cited by 85
Scott, A. W., Tyler, B., Masi, B. C., Upadhyay, U. M., Patta, Y. R., Grossman, R., Basaldella, L., Langer, R., Brem, H., & Cima, M. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.020 · Cited by 83
Minocha, M., Khurana, V., Qin, B., Pal, D., & Mitra, A. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.028 · Cited by 82
Nutlin-Loaded Magnetic Solid Lipid Nanoparticles for Targeted Glioblastoma Treatment
Grillone, A. F., Battaglini, M., Moscato, S., Mattii, L., Fernández, C. D. J., Scarpellini, A., Gıorgı, M., Sinibaldi, E., & Ciofani, G. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0436 · Cited by 82
Implantable drug delivery systems: An overview
Rajgor, N. B., Bhaskar, V., & Patel, M. P. (2011) · Systematic Reviews in Pharmacy · doi:10.4103/0975-8453.86297 · Cited by 81
Tan, A., Eskandar, N. G., Rao, S., & Prestidge, C. A. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0172-9 · Cited by 81
Jambhrunkar, S., Qu, Z. G., Popat, A., Karmakar, S., Xu, C., & Yu, C. (2014) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2014.08.019 · Cited by 77
Self-citationLevina, A., Vieira, A. P., Wijetunga, A. R., Kaur, R., Koehn, J. T., Crans, D. C., & Lay, P. A. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005458 · Cited by 77
Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies
Field, K. M., Jordan, J. T., Wen, P. Y., Rosenthal, M. A., & Reardon, D. A. (2014) · Cancer · doi:10.1002/cncr.28935 · Cited by 76
Stealth coatings for nanoparticles
Hadjesfandiari, N., & Anilkumar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00013-1 · Cited by 75
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study
Mueller, S., Polley, M. C., Lee, B. J., Kunwar, S., Pedain, C., Wembacher-Schroeder, E., Mittermeyer, S., Westphal, M., Sampson, J. H., Vogelbaum, M. A., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0255-0 · Cited by 74
Mittal, S., Klinger, N. V., Michelhaugh, S. K., Barger, G. R., Pannullo, S. C., & Juhász, C. (2017) · Journal of neurosurgery · doi:10.3171/2016.9.jns16452 · Cited by 74
Role of particle shape on efficient and organ-based drug delivery
Nejati, S., Vadeghani, E. M., Khorshidi, S., & Karkhaneh, A. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.109353 · Cited by 74
Dekkers, S., Bouwmeester, H., Bos, P. M. J., Peters, R., Rietveld, A. G., & Oomen, A. G. (2012) · Nanotoxicology · doi:10.3109/17435390.2012.662250 · Cited by 73
Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity
Ho, I. A. W., & SHIM, W. S. N. (2017) · BioMed Research International · doi:10.1155/2017/9634172 · Cited by 73
Taki, H., Kanazawa, T., Akiyama, F., Takashima, Y., & Okada, H. (2012) · Pharmaceuticals · doi:10.3390/ph5101092 · Cited by 72
Sanders, S., & Debinski, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082759 · Cited by 72
Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting
Bouchoucha, M., Béliveau, É., Kleitz, F., Calon, F., & Fortin, M. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01385j · Cited by 71
Nanoparticle Targeting to Neurons in a Rat Hippocampal Slice Culture Model
Walters, R., Kraig, R. P., Medintz, I. L., Delehanty, J. B., Stewart, M. H., Susumu, K., Huston, A. L., Dawson, P. E., & Dawson, G. (2012) · ASN NEURO · doi:10.1042/an20120042 · Cited by 69
Sheykhzadeh, S., Luo, M., Peng, B., White, J., Abdalla, Y., Tang, T., Mäkilä, E. M., Voelcker, N. H., & Tong, W. Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-59146-5 · Cited by 68
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Tan, M. S. A., Parekh, H. S., Pandey, P. M., Siskind, D. J., & Falconer, J. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762563 · Cited by 68
Gerstner, E. R., Emblem, K. E., Chang, K., Vakulenko‐Lagun, B., Yen, Y., Beers, A. L., Dietrich, J., Plotkin, S. R., Catana, C., Hooker, J. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1739 · Cited by 66
WEINGART, J. D., Thompson, R. C., Tyler, B., Colvin, O. M., & Brem, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620519 · Cited by 65
Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management
Upadhaya, P. G., Pulakkat, S., & Patravale, V. B. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00747-y · Cited by 65
Peptide vaccines for the treatment of glioblastoma
Swartz, A. M., Batich, K. A., Fecci, P. E., & Sampson, J. H. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1676-y · Cited by 64
Recinos, V. R., Tyler, B., Bekelis, K., Sunshine, S. B., Vellimana, A. K., Li, K. W., & Brem, H. (2010) · Neurosurgery · doi:10.1227/01.neu.0000365263.14725.39 · Cited by 64
Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model
Masi, B. C., Tyler, B., Bow, H. C., Wicks, R. T., Xue, Y., Brem, H., Langer, R., & Cima, M. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.048 · Cited by 64
Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles
Tyagi, N., De, R., Begun, J., & Popat, A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.030 · Cited by 64
Self-citationThe effect of thermal therapy on the blood-brain barrier and blood-tumor barrier
Patel, B., Yang, P. H., & Kim, A. H. (2020) · International Journal of Hyperthermia · doi:10.1080/02656736.2020.1783461 · Cited by 64
Brown, N. F., McBain, C. A., Nash, S., Hopkins, K., Sanghera, P., Saran, F. H., Phillips, M., Dungey, F. A., Clifton‐Hadley, L., Wanek, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156369 · Cited by 62
Vogelbaum, M. A., Brewer, C. J., Barnett, G. H., Mohammadi, A. M., Peereboom, D. M., Ahluwalia, M. S., & Gao, S. (2018) · Journal of neurosurgery · doi:10.3171/2017.10.jns171845 · Cited by 62
Wick, W., Steinbach, J. P., Platten, M., Hartmann, C. J., Wenz, F. K., von Deimling, A., Shei, P., MOREAU, V., Stoffregen, C., & Combs, S. E. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not100 · Cited by 61
Peviani, M., Palmiero, U. C., Cecere, F., Milazzo, R., Moscatelli, D., & Biffi, A. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.012 · Cited by 60
Delivery of Nanoparticles and Macromolecules across the Blood–Brain Barrier
Nowak, M., Helgeson, M. E., & Mitragotri, S. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900073 · Cited by 60
New molecularly targeted therapies for glioblastoma multiforme.
Polívka, J., Polívka, J., Rohan, V., Topolčan, O., & Ferda, J. (2012) · PubMed · Cited by 59
Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells
Lin, G., Chen, T., Zou, J., Wang, Y., Wang, X., Li, J., Huang, Q., Fu, Z., Zhao, Y., Lin, M. C. M., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00182 · Cited by 59
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors
de la Puente, P., Fettig, N. M., Luderer, M. J., Jin, A. Y., Shah, S., Muz, B., Kapoor, V., Goddu, S. M., Salama, N. N., Tsien, C. I., et al. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.10.042 · Cited by 59
Kang, J. H., Cho, J., & Ko, Y. T. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1497037 · Cited by 58
Kinzel, A., Ambrogi, M., Varshaver, M., & Kirson, E. D. (2019) · Clinical Medicine Insights Oncology · doi:10.1177/1179554918825449 · Cited by 58
Saha, S., Yakati, V., Shankar, G., Jaggarapu, M. M. C. S., Moku, G., Kuncha, M., Banerjee, R., Ramkrishna, S., Srinivas, R., & Chaudhuri, A. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02700a · Cited by 58
Houston, Z. H., Bunt, J., Chen, K., Puttick, S. G., Howard, C. B., Fletcher, N. L., Fuchs, A. V., Cui, J., Ju, Y., Cowin, G., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01299 · Cited by 56
Heggannavar, G. B., Hiremath, C. G., Achari, D. D., Pangarkar, V. G., & Kariduraganavar, M. Y. (2018) · ACS Omega · doi:10.1021/acsomega.8b00152 · Cited by 55
Rahiminejad, A., Dinarvand, R., Johari, B., Nodooshan, S. J., Rashti, A., Rismani, E., Mahdaviani, P., Saltanatpour, Z., Rahiminejad, S., Raigani, M., et al. (2018) · Cell Biology International · doi:10.1002/cbin.11037 · Cited by 55
Wang, W., Wang, L., Liu, S., & Xie, Z. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00508 · Cited by 54
Lam, S. K., Lin, Y., Zinn, P. O., Su, J. M. F., & Pan, I.-W. E. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.10.041 · Cited by 54
Bredlau, A. L., Motamarry, A., Chen, C., McCrackin, M. A., Helke, K. L., Armeson, K. E., Bynum, K., Broome, A., & Haemmerich, D. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461280 · Cited by 54
Escobar, G., Barbarossa, L., Barbiera, G., Norelli, M., Genua, M., Ranghetti, A., Plati, T., Camisa, B., Brombin, C., Cittaro, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05315-0 · Cited by 54
Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review
Ansari, M. A., Chung, I., Rajakumar, G., Alzohairy, M. A., Alomary, M. N., Thiruvengadam, M., Pottoo, F. H., & Ahmad, N. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200116153912 · Cited by 54
Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases
Talekar, M., Tran, T.-H., & Amiji, M. M. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9772-2 · Cited by 53
Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles.
Yadav, K. S., Chuttani, K., Mishra, A. K., & Sawant, K. K. (2016) · PubMed · Cited by 53
Dual Functional Mesoporous Silicon Nanoparticles Enhance the Radiosensitivity of VPA in Glioblastoma
Zhang, H., Zhang, W., Zhou, Y., Jiang, Y., & Li, S. (2017) · Translational Oncology · doi:10.1016/j.tranon.2016.12.011 · Cited by 53
Self-Reporting Photoluminescent Porous Silicon Microparticles for Drug Delivery
Wang, J., Kumeria, T., Bezem, M. T., Wang, J., & Sailor, M. J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09071 · Cited by 53
Self-citationRoberts, R., Smyth, J. W., Will, J. W., Roberts, P., Grek, C. L., Ghatnekar, G. S., Sheng, Z., Gourdie, R. G., Lamouille, S., & Foster, E. J. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110191 · Cited by 53
Maher, S., Alsawat, M., Kumeria, T., Fathalla, D., Fetih, G. N., Santos, A., Habib, F., & Lošić, D. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501249 · Cited by 52
Self-citationMaher, S., Kumeria, T., Wang, Y., Kaur, G., Fathalla, D., Fetih, G. N., Santos, A., Habib, F., Evdokiou, A., & Lošić, D. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600688 · Cited by 52
Self-citationChamberlain, M. C., & Kim, B. T. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2466-0 · Cited by 52
Chen, E. C., Fathi, A. T., & Brunner, A. M. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s141212 · Cited by 52
Goldwirt, L., Canney, M. S., Horodyckid, C., Poupon, J., Mourah, S., Vignot, A., Chapelon, J., & Carpentier, A. C. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2930-5 · Cited by 51
Tumor Vaccines for Malignant Gliomas
Srinivasan, V. M., Ferguson, S. D., Lee, S., Weathers, S.-P. S., Kerrigan, B. C. P., & Heimberger, A. B. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0522-2 · Cited by 51
Reinshagen, C., Bhere, D., Choi, S. H., Hutten, S. J., Nesterenko, I., Wakimoto, H., Roux, E. L., Rizvi, A., Du, W., Minicucci, C., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao3240 · Cited by 51
Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma
Minaei, S. E., Khoei, S., Khoee, S., & karimi, M. R. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.010 · Cited by 51
Dendrimers as Effective Carriers for the Treatment of Brain Tumor
Gorain, B., Choudhury, H., Pandey, M., Amin, M. C. I. M., Singh, B., Gupta, U. D., & Kesharwani, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00010-5 · Cited by 50
Asquier, N., Bouchoux, G., Canney, M. S., Martin, C., Law-Ye, B., Leclercq, D., Chapelon, J., Lafon, C., Idbaïh, A., & Carpentier, A. C. (2019) · Journal of neurosurgery · doi:10.3171/2018.9.jns182001 · Cited by 50
Gonzalez‐Carter, D., Goode, A. E., Kiryushko, D. V., Masuda, S., Hu, S., Rodrigues, R. L., Dexter, D. T., Shaffer, M. S. P., & Porter, A. E. (2019) · Nanoscale · doi:10.1039/c9nr02866h · Cited by 50
Narita, Y. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s58289 · Cited by 49
Graham-Gurysh, E. G., Moore, K. M., Schorzman, A. N., Lee, T., Zamboni, W. C., Hingtgen, S., Bachelder, E. M., & Ainslie, K. M. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c04102 · Cited by 49
Gara, P. M. D., Garabano, N. I., Llansola‐Portoles, M. J., Moreno, M. S., Dodat, D., Casas, O. R., Gonzalez, M. C., & Kotler, M. L. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0741-8 · Cited by 48
Inhaled Amorphous Silica Particulates: What Do We Know About Their Toxicological Profiles?
Warheit, D. B. (2001) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.v20.isuppl.1.120 · Cited by 47
Current status of intratumoral therapy for glioblastoma
Mehta, A. I., Linninger, A. A., Lesniak, M. S., & Engelhard, H. H. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1875-1 · Cited by 47
Jonnalagadda, S., Jonnalagadda, S. K., Alam, M. A., Ronayne, C. T., Nelson, G. L., Solano, L. N., Lueth, E. A., Drewes, L. R., & Mereddy, V. R. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.05.054 · Cited by 47
Müther, M., Koch, R., Weckesser, M., Sporns, P. B., Schwindt, W., & Stummer, W. (2019) · Neurosurgery · doi:10.1093/neuros/nyz199 · Cited by 47
CNS Anticancer Drug Discovery and Development Conference White Paper
Levin, V. A., Tonge, P. J., Gallo, J. M., Birtwistle, M. R., Dar, A. C., Iavarone, A., Paddison, P. J., Heffron, T. P., Elmquist, W. F., Lachowicz, J. E., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov169 · Cited by 46
Buahin, K. G., & Brem, H. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01060216 · Cited by 45
Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma
McCrorie, P., Vasey, C. E., Smith, S. J., Marlow, M., Alexander, C., & Rahman, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.022 · Cited by 45
Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
Pistollato, F., Bremer‐Hoffmann, S., Basso, G., Cano, S. S., Elío, I., Vergara, M. M., Giampieri, F., & Battino, M. A. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0378-5 · Cited by 44
You, Y., Yang, L., He, L., & Chen, T. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01329e · Cited by 44
Reardon, D. A., Kim, T.-M., Frenel, J., Santoro, A., Lopez, J. S., Subramaniam, D. S., Siu, L. L., Rodon, J. A., Tamura, K., Saraf, S., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now212.100 · Cited by 44
Gräfe, C., von der Lühe, M., Weidner, A., Globig, P., Clement, J. H., Dutz, S., & Schacher, F. H. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab0ed0 · Cited by 44
Makharza, S. A., Cirillo, G., Vittorio, O., Valli, E., Voli, F., Farfalla, A., Curcio, M., Iemma, F., Nicoletta, F. P., El‐Gendy, A. A., et al. (2019) · Pharmaceuticals · doi:10.3390/ph12020076 · Cited by 43
Supramaximal resection: A systematic review of its safety, efficacy and feasibility in glioblastoma
Dimou, J., Béland, B., & Kelly, J. J. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.12.021 · Cited by 43
Champeaux-Depond, C., & Weller, J. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03410-1 · Cited by 43
Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma
Sagnella, S. M., Trieu, J., Brahmbhatt, H. N., MacDiarmid, J. A., Macmillan, A., Whan, R. M., Fife, C. M., McCarroll, J. A., Gifford, A. J., Ziegler, D. S., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0738 · Cited by 42
Self-citationFluorescence Diagnosis in Neurooncology: Retrospective Analysis of 653 Cases
Goryaynov, S. A., Александрович, О. В., Golbin, D. A., Chernyshov, K. A., Свистов, Д. В., Владимирович, М. Б., Kim, A. V., Byvaltsev, V. A., Pavlova, G. V., Игоревич, Б. А., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00830 · Cited by 42
Ferreira, N. N., Granja, S., Boni, F. I., Ferreira, L. M. B., Reis, R. M., Baltazar, F., & Gremião, M. P. D. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00713-8 · Cited by 42
Estrogen receptor variant ER ‐α36 promotes tamoxifen agonist activity in glioblastoma cells
Qu, C., Ma, J., Zhang, Y., Han, C., Huang, L., Shen, L., Li, H., Wang, X., Liu, J., & Zou, W. (2018) · Cancer Science · doi:10.1111/cas.13868 · Cited by 41
Hadjipanayis, C. G., Fellows-Mayle, W. K., & DeLuca, N. A. (2008) · Molecular Therapy · doi:10.1038/mt.2008.185 · Cited by 40
Multiple functionalized carbon quantum dots for targeting glioma and tissue imaging
Gao, L., Zhao, X., Wang, J., Wang, Y., Yu, L., Peng, H., & Zhu, J. (2017) · Optical Materials · doi:10.1016/j.optmat.2017.11.044 · Cited by 40
Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
Jungk, C., Warta, R., Möck, A., Friauf, S., Hug, B., Capper, D., Abdollahi, A., Debus, J., Bendszus, M., von Deimling, A., et al. (2019) · Cancers · doi:10.3390/cancers11010122 · Cited by 40
Parisi, S., Corsa, P., Raguso, A., Perrone, A., Cossa, S., Munafò, T., Sanpaolo, G., Donno, E., Clemente, M. A., Piombino, M., et al. (2015) · BioMed Research International · doi:10.1155/2015/620643 · Cited by 39
Ardebili, S. M. M., Zajc, I., Gole, B., Campos, B., Herold‐Mende, C. C., Drmota, S., & Lah, T. T. (2011) · Radiology and Oncology · doi:10.2478/v10019-011-0015-6 · Cited by 38
Vaccine Strategies for Glioblastoma: Progress and Future Directions
Jackson, C. M., Ruzevick, J., Brem, H., & Lim, M. K. (2013) · Immunotherapy · doi:10.2217/imt.12.155 · Cited by 35
MacDiarmid, J. A., Madrid-Weiss, J., Amaro-Mugridge, N. B., Phillips, L., & Brahmbhatt, H. N. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4648 · Cited by 35
Treatment of Glioblastoma Using Multicomponent Silica Nanoparticles
Turan, O., Bielecki, P. A., Perera, V. S., et al. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900118 · Cited by 35
Catarinella, M., Monestiroli, A., Escobar, G., Fiocchi, A., Tran, N. L., Aiolfi, R., Marra, P., Esposito, A., Cipriani, F., Aldrighetti, L. A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505395 · Cited by 34
Crystallisation Behaviour of Pharmaceutical Compounds Confined within Mesoporous Silicon
Jones, E. C. L., & Bimbo, L. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030214 · Cited by 33
Albatany, M., Meakin, S. O., & Bartha, R. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0644-3 · Cited by 32
Heggannavar, G. B., Vijeth, S., & Kariduraganavar, M. Y. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101157 · Cited by 32
Full-ProcessRadiosensitization Based on NanoscaleMetal–Organic Frameworks
Gong, T., Li, Y., Lv, B., Wang, H., Liu, Y., Yang, W., Wu, Y., Jiang, X., Gao, H., Zheng, X., et al. (2020) · Figshare · doi:10.1021/acsnano.9b07898.s001 · Cited by 32
Structure Governs the Deformability of Polymer Particles in a Microfluidic Blood Capillary Model
Sun, H., Björnmalm, M., Cui, J., Wong, E. H. H., Dai, Y., Dai, Q., Qiao, G. G., & Caruso, F. (2015) · ACS Macro Letters · doi:10.1021/acsmacrolett.5b00591 · Cited by 31
Schlenke, P., & Sibrowski, W. (2009) · Transfusion Medicine and Hemotherapy · doi:10.1159/000268061 · Cited by 30
Zeng, X., Wang, Q., Tan, X., Jia, L., Li, Y., Hu, M., Zhang, Z., Bai, X., Zhu, Y., & Yang, X. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0483-1 · Cited by 30
Liang, T., Sang, S., Shao, Q., Chen, C., Deng, Z., Wang, T., & Kang, Q. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01449-8 · Cited by 30
Nanoparticle-mediated drug delivery to high-grade gliomas
Fròsina, G. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.12.375 · Cited by 28
Pérez, J. E., Kopecký, J., Visse, E., Darabi, A., & Siesjö, P. (2020) · BMC Cancer · doi:10.1186/s12885-019-6502-7 · Cited by 27
Jain, S., Dongave, S. M., Date, T., Kushwah, V., Mahajan, R. R., Pujara, N., Kumeria, T., & Popat, A. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00268 · Cited by 26
Self-citationGuzauskas, G. F., Salzberg, M. O., & Wang, B. C. (2018) · CNS Oncology · doi:10.2217/cns-2018-0010 · Cited by 25
Wang, Y., Bi, K., Shu, J., Liu, X., Xu, J., & Deng, G. (2019) · Nanoscale · doi:10.1039/c8nr08497a · Cited by 24
Voth, B. L., Pelargos, P. E., Barnette, N. E., Bhatt, N. S., Chen, C. H. J., Lagman, C., Chung, L. K., Nguyen, T. P., Sheppard, J. P., Romiyo, P., et al. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03479-8 · Cited by 24
Escobar, G., Gentner, B., Naldini, L., & Mazzieri, R. (2014) · OncoImmunology · doi:10.4161/onci.28696 · Cited by 23
Self-citationSilicosis in Current Scenario: A Review of Literature
Sen, S., Mitra, R., Mukherjee, S., Das, P. K., & Moitra, S. (2015) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x11666151026221845 · Cited by 23
Caruso, J. P., Koch, B. J., Benson, P. D., Varughese, E., Monterey, M. D., Lee, A. E., Dave, A. M., Kiousis, S., Sloan, A. E., & Mathupala, S. P. (2017) · Neoplasia · doi:10.1016/j.neo.2016.12.011 · Cited by 22
Noy, J., Chen, F., Akhter, D. T., Houston, Z. H., Fletcher, N. L., Thurecht, K. J., & Stenzel, M. H. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00257 · Cited by 22
Aly, A., Singh, P., Korytowsky, B., Ling, Y., Kale, H. P., Dastani, H. B., Botteman, M. F., & Norden, A. D. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz042 · Cited by 19
Huang, X., Cavalcante, D. P., & Townley, H. E. (2020) · Journal of Nanoparticle Research · doi:10.1007/s11051-019-4720-1 · Cited by 18
Malmström, A., Łysiak, M., Åkesson, L., Falk, I. J., Mudaisi, M., Milos, P., Hallbeck, M., Fomichov, V., Broholm, H., Grunnet, K., et al. (2019) · The Pharmacogenomics Journal · doi:10.1038/s41397-019-0107-z · Cited by 17
Astrocytoma progression scoring system based on the WHO 2016 criteria
Li, Z.-H., Guan, Y., Liu, Q., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36471-4 · Cited by 16
Supratentorial glioblastoma in adults: Identification of subsets and their clinical correlation
Sarkar, C., Sinha, S., Sharma, M. C., Kumar, R., & Mehta, V. S. (2004) · Brain Tumor Pathology · doi:10.1007/bf02482170 · Cited by 14
Head, R. J., Fay, M. F., Cosgrove, L. J., Fung, K. Y. C., Rundle‐Thiele, D., & Martin, J. H. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1385680 · Cited by 14
Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity
Ishiguro, Y., Kobayashi, M., Ideno, M., Narumi, K., Furugen, A., & Iseki, K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.039 · Cited by 14
Cited by
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Lin, H., Liu, C., Hu, A., Zhang, D., Yang, H., & Mao, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 392
Chen, C., Jing, W., Chen, Y., Wang, G., Abdalla, M., Gao, L., Han, M., Shi, C., Li, A., Sun, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn1128 · Cited by 291
Janjua, T. I., Cao, Y., Kleitz, F., Linden, M., Yu, C., & Popat, A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115115 · Cited by 259
Self-citationLiu, X., Cao, Z., Wang, W., Zou, C., Wang, Y., Pan, L., Jia, B., Zhang, K., Zhang, W., Li, W., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12857 · Cited by 132
Metadata
- Authors
- Janjua, T. I., Rewatkar, P., Ahmed-Cox, A., Saeed, I., Mansfeld, F. M., Kulshreshtha, R., Kumeria, T., Ziegler, D. S., Kavallaris, M., Mazzieri, R., & Popat, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 171
- Pages
- 108-138
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3124899091
- Cited by
- 257
- References
- 403
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.